Literature DB >> 24731899

Mindfulness-based cognitive therapy for the treatment of headache pain: A mixed-methods analysis comparing treatment responders and treatment non-responders.

Melissa A Day1, Beverly E Thorn2, Nancy J Rubin3.   

Abstract

OBJECTIVES: Our recent pilot study demonstrated mindfulness-based cognitive therapy (MBCT) is a potentially efficacious headache pain treatment; however, it was not universally effective for all participants. This study sought to explore patient characteristics associated with MBCT treatment response and the potential processes of change that allowed treatment responders to improve and that were potentially lacking in the non-responders.
DESIGN: We implemented a mixed-methods analysis of quantitative and qualitative data. The sample consisted of 21 participants, 14 of whom were classified as treatment responders (≥50% improvement in pain intensity and/or pain interference) and seven as non-responders (<50% improvement).
SETTING: The study was conducted at the Kilgo Headache Clinic and the University of Alabama Psychology Clinic. INTERVENTION: Participants completed an 8-week MBCT treatment for headache pain management. MEASURES: Standardized measures of pain, psychosocial outcomes, and non-specific therapy factors were obtained; all participants completed a post-treatment semi-structured interview.
RESULTS: Quantitative data indicated a large effect size difference between responders and non-responders for pre- to post-treatment change in standardized measures of pain acceptance and catastrophizing, and a small to medium effect size differences on treatment dose indicators. Both groups showed improved psychosocial outcomes. Qualitatively, change in cognitive processes was a more salient qualitative theme within treatment responders; both groups commented on the importance of non-specific therapeutic factors. Barriers to mindfulness meditation were also commented on by participants across groups.
CONCLUSIONS: Results indicated that change in pain related cognitions during an MBCT intervention for headache pain is a key factor underlying treatment response.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Headache pain; Mindfulness-based cognitive therapy; Mixed-methods analysis; Responder analysis

Mesh:

Year:  2014        PMID: 24731899     DOI: 10.1016/j.ctim.2013.12.018

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  13 in total

1.  Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial.

Authors:  Elizabeth K Seng; Alexandra B Singer; Christopher Metts; Amy S Grinberg; Zarine S Patel; Maya Marzouk; Lauren Rosenberg; Melissa Day; Mia T Minen; Richard B Lipton; Dawn C Buse
Journal:  Headache       Date:  2019-09-26       Impact factor: 5.887

Review 2.  Emerging behavioral treatments for migraine.

Authors:  Todd A Smitherman; Rebecca E Wells; Sutapa G Ford
Journal:  Curr Pain Headache Rep       Date:  2015-04

Review 3.  Understanding and Promoting Resiliency in Patients with Chronic Headache.

Authors:  Cynthia M Stonnington; Dhwani J Kothari; Mary C Davis
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

4.  Manual Therapy and Quality of Life in People with Headache: Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Luca Falsiroli Maistrello; Marco Rafanelli; Andrea Turolla
Journal:  Curr Pain Headache Rep       Date:  2019-08-10

Review 5.  Psychological Interventions for the Management of Chronic Pain: a Review of Current Evidence.

Authors:  Ronald S Kaiser; Mira Mooreville; Kamini Kannan
Journal:  Curr Pain Headache Rep       Date:  2015-09

6.  Enhanced mindfulness-based stress reduction in episodic migraine-effects on sleep quality, anxiety, stress, and depression: a secondary analysis of a randomized clinical trial.

Authors:  Shana A B Burrowes; Olga Goloubeva; Kristen Stafford; Patrick F McArdle; Madhav Goyal; B Lee Peterlin; Jennifer A Haythornthwaite; David A Seminowicz
Journal:  Pain       Date:  2022-03-01       Impact factor: 7.926

Review 7.  Mindfulness-based cognitive therapy for residual depressive symptoms and relapse prophylaxis.

Authors:  Zindel V Segal; Kathleen M Walsh
Journal:  Curr Opin Psychiatry       Date:  2016-01       Impact factor: 4.741

8.  Clinimetric properties of the Nepali version of the Pain Catastrophizing Scale in individuals with chronic pain.

Authors:  Saurab Sharma; Pascal Thibault; J Haxby Abbott; Mark P Jensen
Journal:  J Pain Res       Date:  2018-01-31       Impact factor: 3.133

9.  Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up.

Authors:  Licia Grazzi; Emanuela Sansone; Alberto Raggi; Domenico D'Amico; Andrea De Giorgio; Matilde Leonardi; Laura De Torres; Francisco Salgado-García; Frank Andrasik
Journal:  J Headache Pain       Date:  2017-02-04       Impact factor: 7.277

Review 10.  Psychological Considerations in the Assessment and Treatment of Pain in Neurorehabilitation and Psychological Factors Predictive of Therapeutic Response: Evidence and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.

Authors:  Gianluca Castelnuovo; Emanuele M Giusti; Gian Mauro Manzoni; Donatella Saviola; Arianna Gatti; Samantha Gabrielli; Marco Lacerenza; Giada Pietrabissa; Roberto Cattivelli; Chiara A M Spatola; Stefania Corti; Margherita Novelli; Valentina Villa; Andrea Cottini; Carlo Lai; Francesco Pagnini; Lorys Castelli; Mario Tavola; Riccardo Torta; Marco Arreghini; Loredana Zanini; Amelia Brunani; Paolo Capodaglio; Guido E D'Aniello; Federica Scarpina; Andrea Brioschi; Lorenzo Priano; Alessandro Mauro; Giuseppe Riva; Claudia Repetto; Camillo Regalia; Enrico Molinari; Paolo Notaro; Stefano Paolucci; Giorgio Sandrini; Susan G Simpson; Brenda Wiederhold; Stefano Tamburin
Journal:  Front Psychol       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.